Want to see BBIO full AI Analyst Report?
BridgeBio Pharma (BBIO) Q4 2025 Earnings Report
BBIO Q4 2025 EPS Results
- Actual EPS
- -$1.00
- Consensus EPS
- -$0.71
- Beat/Miss
- Missed by -$0.29
- One Year Ago EPS
- -$1.40
BBIO Q4 2025 Revenue Results
- Actual Revenue
- $154.18M
- Expected Revenue
- $146.84M
- Beat/Miss
- Beat by +$7.34M
- YoY Revenue Growth
- +2521.18%
Earnings Announcement Details
- Quarter
- Q4 2025
- Date
- 02/24/2026
- Time
- After Close
- Conference Call
- Tuesday, February 24, 2026
BBIO Upcoming Earnings
BridgeBio Pharma's next earnings date is estimated for February 25, 2027, based on past reporting schedules.
Q4 2025 Earnings Call Audio
BBIO Q4 2025 Earnings Call
0:00 / 0:00
Q4 2025 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
BBIO Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 25, 2027 | 2026 (Q4) | -0.59- | -1 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | -0.54-0.42 | -0.95 | 55.79% (+0.53) | |
| Aug 10, 2026 | 2026 (Q2) | -0.58-0.78 | -0.95 | 17.89% (+0.17) | |
| May 07, 2026 | 2026 (Q1) | -0.68-0.84 | -0.88 | 4.55% (+0.04) | |
| Feb 24, 2026 | 2025 (Q4) | -0.71-1.00 | -1.4 | 28.57% (+0.40) | |
| Oct 29, 2025 | 2025 (Q3) | -0.89-0.95 | -0.86 | -10.47% (-0.09) | |
| Aug 05, 2025 | 2025 (Q2) | -0.79-0.95 | -0.39 | -143.59% (-0.56) | |
| Apr 29, 2025 | 2025 (Q1) | -0.92-0.88 | -0.2 | -340.00% (-0.68) | |
| Feb 20, 2025 | 2024 (Q4) | -1.12-1.40 | -0.96 | -45.83% (-0.44) | |
| Nov 12, 2024 | 2024 (Q3) | -1.00-0.86 | -1.08 | 20.37% (+0.22) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
